Home Rekrutierung

Rekrutierung

Eingeschlossene Patienten 24.419 (Stand 30. September 2026)
Amgevita® (Adalimumab)285
Avtozma® (Tocilizumab)3
Benepali® (Etanercept)1384
Cimzia® (Certolizumab)1083
Enbrel® (Etanercept)2890
Erelzi® (Etanercept)691
Flixabi® (Infliximab)10
Gobivaz® (Golimumab)9
Hukyndra® (Adalimumab)34
Hulio® (Adalimumab)341
Humira® (Adalimumab)2914
Hyrimoz® (Adalimumab)335
Idacio® (Adalimumab)78
Imraldi® (Adalimumab)272
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)235
Kevzara® (Sarilumab)256
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)139
Olumiant® (Baricitinib)577
Orencia® (Abatacept)1009
Remicade® (Infliximab)762
Remsima® (Infliximab)29
Rinvoq® (Upadacitinib)394
Rixathon® (Rituximab)22
RoActemra® (Tocilizumab)1387
Ruxience® (Rituximab)1
Simponi® (Golimumab)488
Truxima® (Rituximab)13
Tyenne® (Tocilizumab)101
Xeljanz® (Tofacitinib)406
Yuflyma® (Adalimumab)121
Zessly® (Infliximab)2
Kontrollen6584